PEDIA within Research Programs Unit
The Pediatric Diabetes Research Group (PEDIA) is within The Research Programs Unit in Faculty of Medicine, University of Helsinki. The current Research Programs are the following (until the end of 2025): Applied Tumor Genomics (ATG), Clinical and Molecular Metabolism (CAMM), Human Microbiome Research (HUMI), Individual Drug Therapy (INDIVIDRUG), SLEEPWELL Research Program, Systems Oncology (ONCOSYS), Translational Cancer Medicine Program (CAN-PRO), Translational Immunology Program (TRIMM) and Stem Cells and Metabolism Research Program (STEMM). RPU director is Henna Tyynismaa. PEDIA, as a part of Clinical and Molecular Metabolism Research Program (CAMM) aims to understand the pathophysiology of diabetes and cardiovascular diseases and renew management of these diseases as well as test preventive strategies. More information: https://www.helsinki.fi/en/faculty-of-medicine/research-programs-unit